Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Stickelmeyer

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Pharmaceutical Biotechnology|August 23, 2002
Formulation development of protein dosage formsMichael J Akers, Vasu Vasudevan, Mary Stickelmeyer
AAPS Pharmscitech|July 18, 2009
FIP position paper on qualification of paddle and basket dissolution apparatusCynthia K Brown, Lucinda Buhse, Horst-Dieter Friedel, et al.
BMC Psychiatry|June 12, 2010
Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanismDavid P McDonnell, Holland C Detke, Richard F Bergstrom, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Pharmaceutical Biotechnology|August 23, 2002
Formulation development of protein dosage formsMichael J Akers, Vasu Vasudevan, Mary Stickelmeyer
AAPS Pharmscitech|July 18, 2009
FIP position paper on qualification of paddle and basket dissolution apparatusCynthia K Brown, Lucinda Buhse, Horst-Dieter Friedel, et al.
BMC Psychiatry|June 12, 2010
Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanismDavid P McDonnell, Holland C Detke, Richard F Bergstrom, et al.
Pageof 1